Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Current Leases (2020 - 2023)

Ensysce Biosciences (ENSC) has disclosed Current Leases for 4 consecutive years, with $2732.0 as the latest value for Q3 2023.

  • On a quarterly basis, Current Leases fell 92.28% to $2732.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $2732.0, a 92.28% decrease, with the full-year FY2022 number at $27315.0, up 9.81% from a year prior.
  • Current Leases was $2732.0 for Q3 2023 at Ensysce Biosciences, down from $10926.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $35403.0 in Q3 2022 to a low of $2732.0 in Q3 2023.
  • A 4-year average of $19615.1 and a median of $19120.0 in 2023 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: grew 11.8% in 2022, then plummeted 92.28% in 2023.
  • Ensysce Biosciences' Current Leases stood at $25500.0 in 2020, then fell by 2.45% to $24874.0 in 2021, then rose by 9.81% to $27315.0 in 2022, then plummeted by 90.0% to $2732.0 in 2023.
  • Per Business Quant, the three most recent readings for ENSC's Current Leases are $2732.0 (Q3 2023), $10926.0 (Q2 2023), and $19120.0 (Q1 2023).